📗 Cite This Artifact
MBP - Myelin Basic Protein
MBP - Myelin Basic Protein
<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#f8f9fa;text-align:center;font-size:1.1em;">MBP - Myelin Basic Protein</th></tr>
<tr><th>Symbol</th><td>MBP</td></tr>
<tr><th>Full Name</th><td>Myelin Basic Protein</td></tr>
<tr><th>Chromosome</th><td>18q23</td></tr>
<tr><th>NCBI Gene ID</th><td>[4155](https://www.ncbi.nlm.nih.gov/gene/4155)</td></tr>
<tr><th>OMIM</th><td>[159430](https://www.omim.org/entry/159430)</td></tr>
<tr><th>Ensembl</th><td>[ENSG00000197971](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000197971)</td></tr>
<tr><th>UniProt</th><td>[P02686](https://www.uniprot.org/uniprot/P02686)</td></tr>
<tr><th>Associated Diseases</th><td>[Multiple Sclerosis](/diseases/multiple-sclerosis), [Alzheimer's Disease](/diseases/alzheimers-disease), Demyelinating Disorders</td></tr>
</table>
</div>
Overview
MBP (Myelin Basic Protein) is a major protein component of the myelin sheath in the central nervous system (CNS), constituting approximately 30% of total myelin protein [1]. MBP is essential for the structural integrity and functional maintenance of myelin, the lipid-rich multilayered membrane that surrounds axons and enables rapid saltatory conduction of nerve impulses.
MBP - Myelin Basic Protein
<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#f8f9fa;text-align:center;font-size:1.1em;">MBP - Myelin Basic Protein</th></tr>
<tr><th>Symbol</th><td>MBP</td></tr>
<tr><th>Full Name</th><td>Myelin Basic Protein</td></tr>
<tr><th>Chromosome</th><td>18q23</td></tr>
<tr><th>NCBI Gene ID</th><td>[4155](https://www.ncbi.nlm.nih.gov/gene/4155)</td></tr>
<tr><th>OMIM</th><td>[159430](https://www.omim.org/entry/159430)</td></tr>
<tr><th>Ensembl</th><td>[ENSG00000197971](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000197971)</td></tr>
<tr><th>UniProt</th><td>[P02686](https://www.uniprot.org/uniprot/P02686)</td></tr>
<tr><th>Associated Diseases</th><td>[Multiple Sclerosis](/diseases/multiple-sclerosis), [Alzheimer's Disease](/diseases/alzheimers-disease), Demyelinating Disorders</td></tr>
</table>
</div>
Overview
MBP (Myelin Basic Protein) is a major protein component of the myelin sheath in the central nervous system (CNS), constituting approximately 30% of total myelin protein [1]. MBP is essential for the structural integrity and functional maintenance of myelin, the lipid-rich multilayered membrane that surrounds axons and enables rapid saltatory conduction of nerve impulses.
The MBP gene encodes a family of isoforms generated by alternative splicing, with the major isoforms being 18.5 kDa, 17.2 kDa, and 21.5 kDa proteins [2]. These isoforms are expressed in a developmentally regulated manner, with different isoforms predominant at different stages of oligodendrocyte maturation and myelination.
MBP has garnered significant attention in neurodegenerative research due to its central role in demyelinating diseases, particularly [multiple sclerosis (MS)](/diseases/multiple-sclerosis), where autoimmunity against MBP is a hallmark of disease pathogenesis [3]. Additionally, myelin abnormalities have been documented in [Alzheimer's disease](/diseases/alzheimers-disease) and other neurodegenerative conditions.
Gene Structure and Isoforms
The MBP gene spans approximately 32 kb on chromosome 18q23 and consists of 11 exons. The gene generates multiple mRNA isoforms through alternative splicing of the primary transcript [4]:
| Isoform | Size (kDa) | Expression Pattern |
|---------|------------|---------------------|
| MBP-C | 21.5 | Early development, early myelination |
| MBP-A | 18.5 | Adult brain, predominant isoform |
| MBP-B | 17.2 | Adult brain, alternative splicing |
| MBP-tr | 14.0 | Minor isoform |
The structural differences between isoforms confer distinct functional properties, including variations in subcellular localization and interaction with other myelin proteins. The 18.5 kDa isoform is the most abundant in adult human brain and is the primary antigen in MBP-specific T-cell responses [5].
Function
Structural Role in Myelin
MBP plays a critical structural role in the myelin sheath:
Signaling Functions
Beyond its structural role, MBP participates in signaling processes:
- Signal transduction: MBP can be phosphorylated, suggesting roles in cell signaling
- Calcium homeostasis: MBP influences calcium signaling in oligodendrocytes
- Cytokine regulation: MBP can modulate inflammatory responses
Interactions
| Partner | Interaction | Function |
|---------|-------------|----------|
| PLP | Structural | Myelin stability |
| MOG | Immune | Autoantigen |
| Actin | Cytoskeletal | Membrane organization |
| CaM | Calcium signaling | Second messenger |
Expression
MBP expression is highly specific to the nervous system:
- Oligodendrocytes: Primary MBP-producing cells in the CNS
- Schwann cells: Express MBP in peripheral nervous system (PNS)
- Developmental regulation: Expression increases dramatically during active myelination (postnatal weeks 2-6 in rodents)
In the brain, MBP is expressed throughout:
- Cerebral white matter
- Cerebellar white matter
- Brainstem
- Spinal cord
The regional distribution correlates with the degree of myelination, with highest levels in areas with dense white matter tracts [7].
Disease Associations
Multiple Sclerosis
MBP is central to [multiple sclerosis pathogenesis](/diseases/multiple-sclerosis) through multiple mechanisms [8]:
The clinical progression of MS correlates with the balance between demyelination and remyelination, with MBP serving as both a marker of myelin integrity and a therapeutic target.
Alzheimer's Disease
Emerging evidence links MBP to [Alzheimer's disease](/diseases/alzheimers-disease) [11]:
Other Demyelinating Conditions
MBP is relevant to several other conditions:
Therapeutic Implications
Targeting MBP offers therapeutic potential for demyelinating diseases:
| Approach | Strategy | Status |
|----------|----------|--------|
| T-cell modulation | Altered peptide ligands | Clinical trials |
| B-cell depletion | Anti-CD20 antibodies | Approved for MS |
| Remyelination | Cleavage proteins | Preclinical |
| MBP replacement | Gene therapy | Investigational |
The challenge in targeting MBP lies in balancing immunosuppressive effects with the need to preserve protective immune responses [12]. Furthermore, promoting remyelination remains challenging due to the limited regenerative capacity of oligodendrocyte precursor cells in chronic lesions [13].
Research Directions
Key questions about MBP in neurodegeneration include:
See Also
- [Myelin Structure](/mechanisms/myelin-structure)
- [Multiple Sclerosis](/diseases/multiple-sclerosis)
- [Oligodendrocyte Function](/cell-types/oligodendrocytes)
- [Demyelination Mechanisms](/mechanisms/demyelination)
- [Remyelination](/mechanisms/remyelination)
External Links
- [NCBI Gene](https://www.ncbi.nlm.nih.gov/gene/4155)
- [UniProt](https://www.uniprot.org/uniprot/P02686)
- [Ensembl](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000197971)
- [HGNC](https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:6922)
References
Pathway Diagram
The following diagram shows the key molecular relationships involving MBP - Myelin Basic Protein discovered through SciDEX knowledge graph analysis:
GWAS Evidence
Genetic associations from the [NHGRI-EBI GWAS Catalog](https://www.ebi.ac.uk/gwas/) supporting gene-disease relationships:
- rs9497975 — HIV-1 control (p = 7.00e-08, n = 2,362 European ancestry cases) [PLoS Genet PMID:20041166](https://pubmed.ncbi.nlm.nih.gov/20041166/)
- rs212388 — Crohn's disease (p = 3.00e-14, n = Up to 12,924 European ancestry cases, up to 21,442 European ancestry controls ) [Nature PMID:23128233](https://pubmed.ncbi.nlm.nih.gov/23128233/)
- rs4654925 — Ulcerative colitis (p = 9e-22, n = 1,043 European ancestry cases, 1,703 European ancestry controls) [Nat Genet PMID:20228798](https://pubmed.ncbi.nlm.nih.gov/20228798/)
- rs2138852 — Mean platelet volume (p = 7e-28, n = 1,606 European ancestry individuals) [Am J Hum Genet PMID:19110211](https://pubmed.ncbi.nlm.nih.gov/19110211/)
- rs12049330 — Major depressive disorder (p = 6.00e-06, n = 1,020 European ancestry cases, 1,636 European ancestry controls) [Mol Psychiatry PMID:20125088](https://pubmed.ncbi.nlm.nih.gov/20125088/)
- rs1128334 — Systemic lupus erythematosus (p = 2.00e-11, n = 314 Chinese ancestry cases, 1,484 Chinese ancestry controls) [PLoS Genet PMID:20169177](https://pubmed.ncbi.nlm.nih.gov/20169177/)
▸Metadataorigin_type: v1_polymorphic_backfill
| slug | genes-mbp |
| kg_node_id | MBP |
| entity_type | gene |
| origin_type | v1_polymorphic_backfill |
| source_table | wiki_pages |
| wiki_page_id | wp-9807899616bd |
| __merged_from | {'merged_at': '2026-05-13', 'unprefixed_id': 'genes-mbp'} |
| _schema_version | 1 |
No provenance edges found
Use ?embed=1 to load the artifact without SciDEX chrome — suitable for iframing into wiki pages or external sites.
<iframe src="http://scidex.ai/artifact/wiki-genes-mbp?embed=1" width="100%" height="600" style="border:0;border-radius:8px"></iframe>
[MBP - Myelin Basic Protein](http://scidex.ai/artifact/wiki-genes-mbp)
http://scidex.ai/artifact/wiki-genes-mbp